| 4.47 Data as of May 24 |  -0.03 / -0.67%Today’s Change | 3.12 Today|||52-Week Range 6.89 | +3.71% Year-to-Date |
| Previous close | 4.50 |
| Today’s open | 4.54 |
| Day’s range | 4.36 - 4.56 |
| Volume | 255,469 |
| Average volume (3 months) | 225,888 |
| Market cap | $169.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -2,111.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,571.58% |
| P/E ratio | NM |
| Price/Sales | 2.41 |
| Price/Book | 3.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| --Medytox Solutions In... | 0.00 | 0.00% |
| GERNGeron Corp | 0.00 | 0.00% |
| INOInovio Pharmaceutica... | +0.02 | +2.90% |
| TROVTrovagene Inc | -0.06 | -0.86% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $54.5M |
| Annual profit (last year) | $1.7M |
| Net profit margin | 3.03% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Mark A. Sirgo, PhD |
Chief Financial Officer, Secretary & Treasurer James A. McNulty, CPA |
Corporate headquarters Raleigh, North Carolina |
.
